Gator Bio
Focus: Gator Bio is a pre-revenue biotechnology company developing next-generation biolayer interferometry (BLI) technology with enhanced signal strength, detection range, and regeneration capabilities for oncology applications. The company is based in Palo Alto, CA and operates at an early stage with minimal public disclosure on employee count or funding.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
4
Should You Work at Gator Bio?
AI assessmentGator Bio is a high-risk, high-optionality early-stage play best suited for founders, platform scientists, and business developers comfortable with uncertainty and betting on technology licensing/partnership as the primary exit path.
Why Work Here
- Early-stage platform technology in a high-value enabling space (BLI detection) with broad oncology applicability and potential licensing/partnership upside
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Gator Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.